The unique activity of the bone morphogenetic protein TGH4 affects the embryonic development of Trichinella spiralis and the establishment of vaccine protection

Wenjie Shi, Yi Liu, Yan Liu, Xue Bai, Yue Liang, Yaming Yang, Fangwei Wu, Mingyuan Liu, Ning XuVeterinary 2025 · DOI

TL;DR

Researchers have identified a novel protein, TGH4, from the parasite Trichinella spiralis that plays a crucial role in its embryonic development. By modifying this protein to remove its bone morphogenetic protein (BMP) activity, they've created a promising vaccine candidate that significantly enhances host immunity and protection against infection.

What Problem Does This Paper Address?

Trichinellosis, a parasitic disease affecting both animals and humans, poses a significant threat to meat safety and public health, with recent outbreaks reported globally. While vaccination is a key strategy for control, identifying effective vaccine antigens remains a major hurdle. Bone morphogenetic proteins (BMPs) are known to be vital for growth and development in many organisms, making them potential targets for antiparasitic vaccines. This study investigates the role of a specific BMP homologue, TGH4, from Trichinella spiralis and explores its potential as a vaccine antigen.

Methods

The researchers employed a multi-pronged approach:

  • Bioinformatics Analysis: They analyzed the TGH4 sequence to predict its molecular weight, signal peptide, and furin cleavage site, and modeled its 3D structure. They also performed sequence alignments and phylogenetic analysis to understand its relationship with other BMPs.
  • Recombinant Protein Expression and Purification: They expressed and purified recombinant TGH4 and a modified version, rTGH4-m (mature, active form), in E. coli. They also created a mutant protein, rTGH4-d, lacking the furin cleavage site to inactivate its BMP activity.
  • In Vitro Studies: Mouse fibroblasts (L929 cell line) were used to assess the BMP activity of the recombinant proteins. Techniques included wound healing assays to evaluate cell migration, CFSE staining for cell proliferation, Western blotting to detect key protein expressions (collagen I, α-SMA, p38-MAPK, Smad proteins), and flow cytometry.
  • In Vivo Studies: BALB/c mice and SD rats were used for immunization and infection experiments. This involved:
  • Active Immunity Evaluation: Mice were immunized with rTGH4, rTGH4-d, or adjuvant, followed by infection with T. spiralis. Larvae in muscle tissue were counted to assess protection.
  • Parasite Experiments (In Vitro): Adult T. spiralis worms were cultured with recombinant proteins or immune sera to assess their effect on newborn larvae (NBL) production.
  • NBL Infection Experiments: NBL were incubated with immune sera and then used to infect mice to evaluate the infectivity of NBL.
  • Immune Cell Analysis: Flow cytometry was used to analyze immune cell populations (B cells, T cells, macrophages) in the spleen and peritoneal cavity of infected mice.
  • Cytokine Analysis: Serum levels of various pro- and anti-inflammatory cytokines were measured using ELISA.
  • Antibody Detection: Indirect ELISA was used to quantify specific antibody subclasses (IgG, IgG1, IgG2a, IgA) in the serum of immunized mice.

Datasets

Not explicitly discussed as datasets in the traditional machine learning sense. The study utilizes in vitro cell cultures and in vivo animal models infected with Trichinella spiralis (ISS534 strain).

Key Insights and Ideas

  • TGH4's Dual Role: The study reveals that TGH4 has a dual function: its active C-terminal mature form (rTGH4-m) possesses BMP activity that promotes T. spiralis embryonic development, while the full-length TGH4, upon cleavage, releases this active form.
  • BMP Activity Hinders Immunity: Crucially, the BMP activity of TGH4 appears to negatively regulate the host's immune response, hindering the establishment of effective protection against T. spiralis. This is a significant finding for vaccine development, suggesting that removing this activity could be beneficial.
  • Targeting Embryonic Development: The research highlights that interfering with T. spiralis embryonic development is a viable strategy for vaccine-induced protection.
  • rTGH4-d as a Promising Vaccine Candidate: The mutant protein rTGH4-d, lacking BMP activity, proved to be a potent vaccine candidate. It induced a strong immune response, reduced larval burden, and enhanced host resistance without promoting parasite development.
  • Immune Modulation by rTGH4-d: rTGH4-d appears to shift the immune response towards a type I profile (higher IgG2a, increased IFN-γ) and promotes the differentiation of macrophages, leading to a more robust defense against the parasite.

Key Results

  • Recombinant TGH4 and rTGH4-m inhibited mouse fibroblast migration and proliferation in vitro.
  • rTGH4-m promoted the development of T. spiralis embryos into larvae.
  • Blocking natural TGH4 with anti-TGH4 serum increased larval mortality.
  • Immunization with rTGH4-d significantly reduced the number of T. spiralis larvae in mice compared to adjuvant controls (reduction rate of 43.204%).
  • rTGH4-d immunization led to a significant increase in specific IgG2a antibodies and IFN-γ levels, indicative of a type I immune response.
  • rTGH4-d also modulated immune cell populations, increasing the proportion of total T cells and promoting macrophage differentiation.

Limitations and Future Work

  • Cross-Reactivity: The study notes that the active region of TGH4-m shows conservation with mammalian BMP receptors, suggesting potential cross-reactivity. Future work should focus on avoiding this in vaccine design.
  • Mechanism of rTGH4: While rTGH4-m's effects are linked to BMP signaling, rTGH4's similar effects in vitro were not dependent on BMP signaling, suggesting an alternative mechanism that requires further investigation.
  • Further Vaccine Optimization: The authors suggest that modifying BMP homologues from other parasites to eliminate their BMP activity could be a valuable strategy for developing effective vaccines. Further studies could explore the precise mechanisms by which rTGH4-d enhances adaptive immunity.

Summary updated

Abstract

In recent years, animal outbreaks of trichinellosis have been reported in Mexico, China, Algeria, Croatia and others, which is a challenge to meat safety and public health. Vaccination is an important means to control trichinellosis, but one of the main challenges in vaccine development is screening for protective candidate antigens. Bone morphogenetic proteins (BMP)), which are potential vaccine research targets, play key roles in the growth and development of metazoans. The BMP homologue TGH4 was identified from Trichinella spiralis (T. spiralis), and recombinant C-terminal mature rTGH4-m had BMP activity and exerted regulatory effects on both mouse fibroblast and T. spiralis embryonic development. The construction of a protein mutant without activation potential confirmed that BMP activity had a negative regulatory effect on the establishment of immune protection by affecting the innate, adaptive, and humoral immunity of mice. Stripping protein activity can enhance immune protection and host resistance to T. spiralis. Our findings demonstrate that the TGH4 mutant is an important vaccine candidate antigen that blocks embryonic development, kills larvae, and provides insight into parasite vaccine research.
BibTeX
@inproceedings{shi2025unique,
  author = {Wenjie Shi and Yi Liu and Yan Liu and Xue Bai and Yue Liang and Yaming Yang and Fangwei Wu and Mingyuan Liu and Ning Xu},
  title = {{The unique activity of the bone morphogenetic protein TGH4 affects the embryonic development of Trichinella spiralis and the establishment of vaccine protection}},
  booktitle = {Veterinary},
  year = {2025},
  doi = {10.1186/s13567-025-01473-4},
}
Figure